Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Jan 1, 2017 | $313B |
| FY2017, ended Dec 31, 2017 | $375B |
| FY2018, ended Dec 30, 2018 | $339B |
| FY2019, ended Dec 29, 2019 | $384B |
| FY2020, ended Jan 3, 2021 | $414B |
| FY2021, ended Jan 2, 2022 | $450B |
| FY2022, ended Jan 1, 2023 | $460B |
| FY2023, ended Dec 31, 2023 | $378B |
| FY2024, ended Dec 29, 2024 | $349B |
| FY2025, ended Dec 28, 2025 | $500B |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | $653B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Jan 1, 2017 | $71.9B |
| FY2017, ended Dec 31, 2017 | $76.5B |
| FY2018, ended Dec 30, 2018 | $81.6B |
| FY2019, ended Dec 29, 2019 | $82.1B |
| FY2020, ended Jan 3, 2021 | $82.6B |
| FY2021, ended Jan 2, 2022 | $78.7B |
| FY2022, ended Jan 1, 2023 | $80.0B |
| FY2023, ended Dec 31, 2023 | $85.2B |
| FY2024, ended Dec 29, 2024 | $88.8B |
| FY2025, ended Dec 28, 2025 | $94.2B |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | $99.3B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Jan 1, 2017 | $16.5B | $15.5B |
| FY2017, ended Dec 31, 2017 | $1.30B | $17.8B |
| FY2018, ended Dec 30, 2018 | $15.3B | $18.5B |
| FY2019, ended Dec 29, 2019 | $15.1B | $19.9B |
| FY2020, ended Jan 3, 2021 | $14.7B | $20.2B |
| FY2021, ended Jan 2, 2022 | $20.9B | $19.8B |
| FY2022, ended Jan 1, 2023 | $17.9B | $17.2B |
| FY2023, ended Dec 31, 2023 | $35.2B | $18.2B |
| FY2024, ended Dec 29, 2024 | $14.1B | $19.8B |
| FY2025, ended Dec 28, 2025 | $26.8B | $19.7B |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | $16.1B | $20.6B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Jan 1, 2017 | $19.0B |
| FY2017, ended Dec 31, 2017 | $17.8B |
| FY2018, ended Dec 30, 2018 | $18.1B |
| FY2019, ended Dec 29, 2019 | $17.3B |
| FY2020, ended Jan 3, 2021 | $14.0B |
| FY2021, ended Jan 2, 2022 | $14.5B |
| FY2022, ended Jan 1, 2023 | $12.9B |
| FY2023, ended Dec 31, 2023 | $21.9B |
| FY2024, ended Dec 29, 2024 | $24.1B |
| FY2025, ended Dec 28, 2025 | $19.7B |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | $16.9B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Jan 1, 2017 | $27.1B |
| FY2017, ended Dec 31, 2017 | $34.6B |
| FY2018, ended Dec 30, 2018 | $30.5B |
| FY2019, ended Dec 29, 2019 | $27.7B |
| FY2020, ended Jan 3, 2021 | $37.1B |
| FY2021, ended Jan 2, 2022 | $35.9B |
| FY2022, ended Jan 1, 2023 | $41.2B |
| FY2023, ended Dec 31, 2023 | $30.8B |
| FY2024, ended Dec 29, 2024 | $38.4B |
| FY2025, ended Dec 28, 2025 | $49.9B |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | $44.7B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 11.3% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Jan 1, 2017 | 2.71B |
| FY2017, ended Dec 31, 2017 | 2.68B |
| FY2018, ended Dec 30, 2018 | 2.66B |
| FY2019, ended Dec 29, 2019 | 2.63B |
| FY2020, ended Jan 3, 2021 | 2.63B |
| FY2021, ended Jan 2, 2022 | 2.63B |
| FY2022, ended Jan 1, 2023 | 2.60B |
| FY2023, ended Dec 31, 2023 | 2.41B |
| FY2024, ended Dec 29, 2024 | 2.41B |
| FY2025, ended Dec 28, 2025 | 2.41B |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | 2.41B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Jan 1, 2017 | $8.98B | $878M |
| FY2017, ended Dec 31, 2017 | $6.36B | $962M |
| FY2018, ended Dec 30, 2018 | $5.87B | $978M |
| FY2019, ended Dec 29, 2019 | $6.75B | $977M |
| FY2020, ended Jan 3, 2021 | $3.22B | $1.00B |
| FY2021, ended Jan 2, 2022 | $3.46B | $1.14B |
| FY2022, ended Jan 1, 2023 | $6.04B | $1.14B |
| FY2023, ended Dec 31, 2023 | $5.05B | $1.16B |
| FY2024, ended Dec 29, 2024 | $2.43B | $1.18B |
| FY2025, ended Dec 28, 2025 | $5.95B | $1.35B |
| Trailing 12 months to Sep 27, 2026 (through Q3 FY2026) | $7.88B | $1.42B |
Valuation
At current price- Market Cap
- $647B
- P/E
- 40.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.5×
- Price / Book
- 7.9×
- EV / EBITDA
- 25.2×
Growth
Trailing 12 months- Revenue (TTM)
- $99.3B
- Revenue Growth YoY
- 7.8%
- Revenue CAGR 3Y
- 5.6%
- Revenue CAGR 5Y
- 2.7%
- EPS Growth YoY
- −36.4%
- Net Income Growth YoY
- −35.9%
Profitability
Trailing 12 months- Gross Margin
- 67.6%
- Operating Margin
- —
- Net Margin
- 16.2%
- FCF Margin
- 20.7%
- Return on Equity
- 20.0%
Earnings
Trailing 12 months- Net Income
- $16.1B
- EPS (diluted)
- $6.58
- EBITDA
- $26.8B
- Operating Income
- —
Balance Sheet
As of Sep 27, 2026- Cash and cash equivalents
- $16.9B
- Total Debt
- $44.7B
- Net Debt
- $27.7B
- Total Assets
- $197B
- Total Liabilities
- $116B
- Shareholders' Equity
- $81.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $26.2B
- Capital Expenditure
- $5.57B
- Free Cash Flow
- $20.6B
Dividends and risk
Last 12 months- Dividend Yield
- 2.0%
- Dividend / Share
- $5.28
- Beta (5Y)
- 0.21
Every ratio is calculated from the company’s reported figures.